Stephen P. Robertson - 21 Aug 2026 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Reporting relationship: Chief Legal Officer
Issuer ticker: AUPH
Reported as of: 21 Aug 2026
Net transaction value: -$355,946
SEC form: 4
Accepted by SEC: 25 Aug 2026, 21:29:28 UTC
Prior SEC filing: 20 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen P. Robertson

Key filing fact

Stephen P. Robertson filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 25 Aug 2026.

Key facts

This page summarizes Stephen P. Robertson's Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Aug 2026, 21:29.

Change

Previous filing in this sequence was filed on 20 May 2026.
Current net transaction value: -$355,946.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001837798 Primary reporting owner

Robertson Stephen P.

Relationship: Chief Legal Officer
Address: #140, 14315 - 118 AVENUE, EDMONTON, ALBERTA, CANADA
Signature: /s/ Stephen P. Robertson
Signature date: 25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AUPH transaction

Common Stock

Sale

Transaction value: $355,946
Shares: -20,975
Change %: -3.4%
Price: $16.97
Shares after: 600,787
Date: 21 Aug 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Performance Stock Units (PSUs) related to the February 28, 2025 performance award.

Footnote F2

The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F3

Includes 360 common shares that were acquired on May 29, 2026 by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan.